ReCor Taps Otsuka’s Pharma Know-How For Renal Denervation Push
This article was originally published in Clinica
ReCor Medical has enlisted Otsuka, a diversified healthcare group which houses one of Japan’s largest pharma companies, as the Asian commercialization partner for its Paradise ultrasound-based renal denervation system for treating hypertension.
You may also be interested in...
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.